117 related articles for article (PubMed ID: 8149272)
21. Goodpasture-like syndrome induced by D-penicillamine in a patient with systemic sclerosis: report and review of the literature.
Derk CT; Jimenez SA
J Rheumatol; 2003 Jul; 30(7):1616-20. PubMed ID: 12858467
[TBL] [Abstract][Full Text] [Related]
22. Treatment of systemic sclerosis with D-penicillamine. A new method of observing the effects of treatment.
Bluestone R; Grahame R; Holloway V; Holt PJ
Ann Rheum Dis; 1970 Mar; 29(2):153-8. PubMed ID: 5427411
[No Abstract] [Full Text] [Related]
23. D-penicillamine-induced pemphigus vulgaris in a patient with scleroderma-rheumatoid arthritis overlap syndrome.
Szegedi A; Surányi P; Szücs G; Kiss M; Hunyadi J; Gaál J
Acta Derm Venereol; 2004; 84(4):318-9. PubMed ID: 15339083
[No Abstract] [Full Text] [Related]
24. Transient acantholytic dermatosis (Grover's disease) in a patient with progressive systemic sclerosis treated with D-penicillamine.
Zvulunov A; Grunwald MH; Avinoach I; Halevy S
Int J Dermatol; 1997 Jun; 36(6):476-7. PubMed ID: 9248901
[No Abstract] [Full Text] [Related]
25. [Obliterating bronchiolitis induced by D-penicillamine in the female patient with systemic scleroderma].
Alekperov RT; Avdeev SN; Kotovskaia MA
Ter Arkh; 2004; 76(3):74-6. PubMed ID: 15108466
[No Abstract] [Full Text] [Related]
26. [Marked proteinuria in the course of penicillamine treatment of progressive systemic sclerosis].
Filipecki S; Dabrowska B; Szczepański A; Glyda J
Pol Tyg Lek; 1971 Nov; 26(46):1780-1. PubMed ID: 5131995
[No Abstract] [Full Text] [Related]
27. [Extracapillary glomerulonephritis with anti-myeloperoxidase antibodies in 2 patients with systemic scleroderma treated with penicillamine D].
Kyndt X; Ducq P; Bridoux F; Reumaux D; Makdassi R; Gheerbrant JD; Vanhille P
Presse Med; 1999 Jan; 28(2):67-70. PubMed ID: 9989295
[TBL] [Abstract][Full Text] [Related]
28. Lupus erythematosus-like eruption due to D-penicillamine in progressive systemic sclerosis.
Tsankov NK; Lazarova AZ; Vasileva SG; Obreshkova EV
Int J Dermatol; 1990 Oct; 29(8):571-4. PubMed ID: 2147020
[TBL] [Abstract][Full Text] [Related]
29. Nephrotic syndrome induced by penicillamine.
Stein J; Smythe HA
Can Med Assoc J; 1968 Mar; 98(10):505-7. PubMed ID: 5645186
[No Abstract] [Full Text] [Related]
30. The toxicity of D-penicillamine in systemic sclerosis.
Steen VD; Blair S; Medsger TA
Ann Intern Med; 1986 May; 104(5):699-705. PubMed ID: 2938530
[TBL] [Abstract][Full Text] [Related]
31. [Penicillamine in the treatment of scleroderma].
Kobíková M; Stáva Z
Cesk Dermatol; 1973 Dec; 48(6):408-10. PubMed ID: 4771784
[No Abstract] [Full Text] [Related]
32. [Progressive systemic sclerosis with pancytopenia, polymyositis and complete heart block developing after D-penicillamine therapy: a case report].
Matsumura T; Kabashima T; Kono I; Yamane K; Sakurai T; Yamaguchi I; Kashiwagi H
Nihon Naika Gakkai Zasshi; 1985 Jul; 74(7):958-63. PubMed ID: 4056558
[No Abstract] [Full Text] [Related]
33. [A case of myasthenia gravis caused by D-penicillamine therapy].
Susa S; Akiba J; Kurimura M; Kurita K; Daimon M; Manaka H; Yamatani K; Kato T
Nihon Naika Gakkai Zasshi; 1998 Dec; 87(12):2513-5. PubMed ID: 9922674
[No Abstract] [Full Text] [Related]
34. Penicillamine-induced polymyositis.
Leden I; Libelius R
Scand J Rheumatol; 1985; 14(1):90-3. PubMed ID: 4001884
[No Abstract] [Full Text] [Related]
35. In vitro inhibition of hematopoiesis in a patient with systemic sclerosis treated with D-penicillamine.
Katayama Y; Kohriyama K; Matsui T
J Rheumatol; 1999 Nov; 26(11):2493-5. PubMed ID: 10555917
[TBL] [Abstract][Full Text] [Related]
36. Pulmonary involvement in systemic sclerosis due to therapy and as a complication.
Chiappini F; Zoli A; Maugeri L
Monaldi Arch Chest Dis; 2005 Jun; 63(2):111-3. PubMed ID: 16128227
[TBL] [Abstract][Full Text] [Related]
37. [Allergic-toxic liver damage due to D-penicillamine].
Rau R; Weber S; Böni A
Schweiz Med Wochenschr; 1972 Aug; 102(34):1226-8. PubMed ID: 5055042
[No Abstract] [Full Text] [Related]
38. [Minimal changes nephrotic syndrome associated to penicillamine treatment].
Basterrechea MA; de Arriba G; García-Martín F; Sánchez-Heras M; Giménez-Vega E; Sánchez J
Nefrologia; 2004; 24(2):183-7. PubMed ID: 15219094
[TBL] [Abstract][Full Text] [Related]
39. Penicillamine for systemic sclerosis?
Drug Ther Bull; 1974 Sep; 12(19):75-6. PubMed ID: 4469492
[No Abstract] [Full Text] [Related]
40. Vesicular lesions in a woman with progressive systemic sclerosis. Penicillamine-induced intradermal vesicles: an example of human lathyrism.
Godar JM; Norins AL
Arch Dermatol; 1992 Jul; 128(7):977-8, 980-1. PubMed ID: 1626968
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
